Contribution of cystatin C gene polymorphisms to cerebral white matter lesions

Cerebrovascular Diseases

Volumn 32, Issue 5, 2011, Pages 489-496

  Mitaki, Shingo ^a   Nagai, Atsushi ^a   Sheikh, Abdullah M ^a   Terashima, Masaharu ^b   Isomura, Minoru ^a   Nabika, Toru ^a   Yamaguchi, Shuhei ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b TOKAI GAKUEN UNIVERSITY   (Japan)

Author keywords

Arteriosclerosis; Cystatin C; Polymorphism; White matter lesion

Indexed keywords

CYSTATIN C; MESSENGER RNA;

ADULT; AGE DISTRIBUTION; AGED; AMINO ACID SUBSTITUTION; ARTICLE; ASTROCYTOMA; BRAIN DISEASE; CEREBRAL WHITE MATTER LESION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC TRANSFECTION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING; WHITE MATTER;

AGED; ALLELES; BRAIN DISEASES; CASE-CONTROL STUDIES; CYSTATIN C; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LEUKOENCEPHALOPATHIES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES;

EID: 80155189685     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000331921     Document Type: Article

References (31)

1. Abrahamson M, Olafsson I, Palsdottir A, Ulvs back M, Lundwall A, Jensson O, Grubb A: Structure and expression of the human cystatin Cgene. Biochem J 1990; 268:287-294. (Pubitemid 20193964)
2. Bernstein HG, Kirschke H, Wiederanders B, Pollak KH, Zipress A, Rinne A: The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review. Mol Chem Neuropathol 1996; 27: 225-247. (Pubitemid 26142648)
3. Dharnidharka VR, Kwon C, Stevens G: Serum cystatin c is superior to serum creati-nine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40:221-226. (Pubitemid 34827638)
4. Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS: Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006; 145: 237-246. (Pubitemid 46768607)
5. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049-2060. (Pubitemid 40664306)
6. Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-2483. (Pubitemid 43855050)
7. Tanoi Y, Okeda R, Budka H: Binswanger's encephalopathy: serial sections and morphometry of the cerebral arteries. Acta Neu-ropathol 2000; 100: 347-355. (Pubitemid 30497002)
8. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, Ridker PM, Libby P, Chapman HA: Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999; 104:1191-1197. (Pubitemid 29536290)
9. Grubb A: Diagnostic value of analysis of cys-tatin C and protein HC in biological fluids. Clin Nephrol 1992; 38(suppl 1):S20-S27. (Pubitemid 23092541)
10. Eriksson P, Deguchi H, Samnegard A, Lund-man P, Boquist S, Tornvall P, Ericsson CG, Bergstrand L, Hansson LO, Ye S, Hamsten A: Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler Thromb Vasc Biol 2004; 24:551-557. (Pubitemid 38326152)
11. Benussi L, Ghidoni R, Steinhoff T, Alberici A, Villa A, Mazzoli F, Nicosia F, Barbiero L, Broglio L, Feudatari E, Signorini S, Finckh U, Nitsch RM, Binetti G: Alzheimer disease-associated cystatin C variant undergoes im-pa ired secretion. Neurobiol Dis 2003; 13: 15-21. (Pubitemid 36561594)
12. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987; 149:351-356. (Pubitemid 17104996)
13. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H: Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43:1683-1689. (Pubitemid 23307935)
14. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S: Modification of the modification of diet in renal disease (MDRD) study equation for Japan. Am J Kidney Dis 2007; 50: 927-937. (Pubitemid 350130278)
15. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001; 25:402-408. (Pubitemid 34164012)
16. Shimode K, Fujihara S, Nakamura M, Ko-bayashi S, Tsunematsu T: Diagnosis of cerebral amyloid angiopathy by enzyme-linked immunosorbent assay of cystatin C in cere-brospinal fluid. Stroke 1991; 22:860-866.
17. Zapata C, Carollo C, Rodriguez S: Sampling variance and distribution of the d' measure of overall gametic disequilibrium between multiallelic loci. Ann Hum Genet 2001; 65: 395-406.
18. Zhao JH, Curtis D, Sham PC: Model-free analysis and permutation tests for allelic associations. Hum Hered 2000; 50: 133-139.
19. Wada M, Nagasawa H, Kawanami T, Kurita K, Daimon M, Kubota I, Kayama T, Kato T: Cystatin C as an index of cerebral small vessel disease: results of a cross-sectional study in community-based Japanese elderly. Eur J Neurol 2009; 17:383-390.
20. Lindholt JS, Erlandsen EJ, Henneberg EW: Cystatin C deficiency is associated with the progression of small abdominal aortic aneu-rysms. Br J Surg 2001; 88:1472-1475. (Pubitemid 32989466)
21. Bengtsson E, To F, Hakansson K, Grubb A, Branen L, Nilsson J, Jovinge S: Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005; 25:2151-2156. (Pubitemid 41416314)
22. Luc G, Bard JM, Lesueur C, Arveiler D, Evans A, Amouyel P, Ferrieres J, Juhan-Vague I, Fruchart JC, Ducimetiere P: Plasma cys-tatin-C and development of coronary heart disease: the prime study. Atherosclerosis 2006; 18 5: 375-380.
23. Ix JH, Shlipak MG, Chertow GM, Whooley MA: Association of cystatin c with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the heart and soul study. Circulation 2007; 115:173-179. (Pubitemid 46105715)
24. Parikh NI, Hwang SJ, Yang Q, Larson MG, Guo CY, Robins SJ, Sutherland P, Benjamin EJ, Levy D, Fox CS: Clinical correlates and heritability of cystatin c (from the Framing-ham Offspring Study). Am J Cardiol 2008; 102:1194-1198.
25. Taglieri N, Koenig W, Kaski JC: Cystatin c and cardiovascular risk. Clin Chem 2009; 55: 1932-1943.
26. Pardell H, Armario P, Hernandez R: Patho-genesis and epidemiology of arterial hypertension. Drugs 1998; 56(suppl 2):1-10.
27. Schmidt R, Schmidt H, Kapeller P, Lechner A, Fazekas F: Evolution of white matter lesions. Cerebrovasc Dis 2002; 13 (s uppl 2):16-20. (Pubitemid 34233904)
28. Ovbiagele B, Saver JL: Cerebral white matter hyperintensities on MRI: current concepts and therapeutic implications. Cerebrovasc Dis 2006; 22:83-90. (Pubitemid 44114448)
29. Balbin M, Grubb A, Abrahamson M: An Ala/Thr variation in the coding region of the human cystatin C gene (CST3) detected as a Sstii polymorphism. Hum Genet 1993; 92: 206-207. (Pubitemid 23272291)
30. Benedikz E, Merz GS, Schwenk V, Johansen TE, Wisniewski HM, Rushbrook JI: Cellular processing of the amyloidogenic cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. Amyloid 1999; 6:172-182. (Pubitemid 29483008)
31. Wang ZZ, Jensson O, Thorsteinsson L, Vinters HV: Microvascular degeneration in hereditary cystatin C amyloid angiopathy of the brain. APMIS 1997; 105:41-47. (Pubitemid 27504555)